Mesoporous silica-based dosage forms improve bioavailability of poorly soluble drugs in pigs: case example fenofibrate.

about

Mesoporous silica-based dosage forms improve bioavailability of poorly soluble drugs in pigs: case example fenofibrate.

Item

http://www.wikidata.org/entity/Q38669102

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

2017年论文

@zh

2017年论文

@zh-cn

name

Mesoporous silica-based dosage ...... igs: case example fenofibrate.

@en

type

Item

label

Mesoporous silica-based dosage ...... igs: case example fenofibrate.

@en

prefLabel

Mesoporous silica-based dosage ...... igs: case example fenofibrate.

@en

P1476

Mesoporous silica-based dosage ...... igs: case example fenofibrate.

@en

P2093

Alena Wieber

http://www.w3.org/2001/XMLSchema#string

Christoph Saal

http://www.w3.org/2001/XMLSchema#string

Dieter Lubda

http://www.w3.org/2001/XMLSchema#string

Elisabeth Herbert

http://www.w3.org/2001/XMLSchema#string

Jennifer B Dressman

http://www.w3.org/2001/XMLSchema#string

Joseph P O'Shea

http://www.w3.org/2001/XMLSchema#string

Vanessa Witt

http://www.w3.org/2001/XMLSchema#string

P2860

Increasing the oral bioavailability of the poorly water soluble drug itraconazole with ordered mesoporous silica

Ordered mesoporous silica material SBA-15: a broad-spectrum formulation platform for poorly soluble drugs

Supersaturating drug delivery systems: the answer to solubility-limited oral bioavailability?

Mesoporous silicon in drug delivery applications.

Using polymeric precipitation inhibitors to improve the absorption of poorly water-soluble drugs: A mechanistic basis for utility.

In vivo methods for drug absorption - comparative physiologies, model selection, correlations with in vitro methods (IVIVC), and applications for formulation/API/excipient characterization including food effects.

Mesoporous silica formulation strategies for drug dissolution enhancement: a review.

In vitro dissolution models for the prediction of in vivo performance of an oral mesoporous silica formulation.

Lipidic dispersion to reduce food dependent oral bioavailability of fenofibrate: In vitro, in vivo and in silico assessments.

Comparison of in vitro tests at various levels of complexity for the prediction of in vivo performance of lipid-based formulations: case studies with fenofibrate.

P304

1284-1292

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/JPHP.12767

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Caitriona M O'Driscoll

Brendan T. Griffin

Kalpa Nagarsekar

P577

2017-06-20T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28631822

http://www.w3.org/2001/XMLSchema#string